Online Program

Collaborative drug therapy management policy implementation: Lessons learned by community pharmacists and other health care providers

Monday, November 4, 2013 : 3:30 p.m. - 3:50 p.m.

Tara Earl, PhD, MSW, Health Education and Social Programs, ICF International, Inc., Atlanta, GA
Margie Snyder, PharmD, MPH, PHPR Department, Purdue University, Indianapolis, IN
Siobhan Gilchrist, JD, MPH, IHRC, Inc., Centers for Disease Control and Prevention, Atlanta, GA
Michael Greenberg, JD, MPH, Health Education and Social Programs, Division of Public Health and Survey Research, ICF International, Inc., Atlanta, GA
Holly Heisler, MPH, MBA, ICF International, Atlanta, GA
Michelle Revels, MA, Health Education and Social Programs, Division of Public Health and Survey Research, ICF International, Atlanta, GA
Dyann Matson-Koffman, DrPH, MPH, CHES, Office of the Associate Director for Science, Centers for Disease Control and Prevention, Atlanta, GA
Few studies have examined the impact of how scope of practice policies authorizing pharmacists to perform patient care services collaboratively with other providers are implemented in community pharmacy settings. These case studies examine barriers, facilitators and lessons learned from three sites where pharmacists and providers perform collaborative drug therapy management (CDTM) to improve patient health outcomes. In-depth qualitative case studies were conducted in three community-based pharmacy practice settings in Arizona, Iowa and North Carolina from May-July 2012. Sites were selected using three criteria: 1) duration—whether CDTM was newly implemented vs. well established; 2) access—of the practice environment (e.g., chain pharmacy) by the intended population; and 3) scope—of CDTM services provided. We conducted site visits and collected information using audio-recorded, semi-structured interviews and written notes with key informants (i.e., pharmacists, physicians, administrators, and other staff). Key themes emerged for implementing successful collaborative care: (1) developing trust and support through networking to increase buy-in among medical professionals. (2) partnering with academic institutions and pharmacy residency programs to enable pharmacies to deliver more care to more patients; (3) establishing informal collaborations between pharmacists and other providers (i.e., drug therapy recommendations), to maintain high-quality patient care when formal collaborations were not feasible; and (4) the importance of compensating pharmacists for CDTM services. Other facilitators and barriers will be presented during this session. These case studies of practices implementing CDTM policies show promise for improving patient health outcomes. The findings can be used to strengthen implementation strategies for CDTM services.

Learning Areas:

Chronic disease management and prevention
Other professions or practice related to public health
Provision of health care to the public

Learning Objectives:
Identify and describe strategies employed by pharmacists and other health care providrs in establishing collaborative practices to perform CDTM in community-based pharmacy settings, as well as discuss key challenges to expanding these practices.

Keyword(s): Chronic (CVD), Pharmacists

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been engaged in this type of research for approximately seven years. I have published several papers related to the study of pharmacist services and pharmacist-physician professional relationships and have been the Principal or Co-Investigator on several related grants. For this project, I served as the lead site visitor and, therefore, am very familiar with the "lessons learned" discussed.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.